Navigation Links
Patient Negligence - Significant Problem In The Early Detection Of Breast Cancer

Breast cancer is the most common type of cancer among women. Despite the awareness programmes and the massive screening strategies, it has not possible to eliminate the fear associated with the disease. Mammography is one of the routine tests // used in the early identification of the disease.

However, a new study finds the number of women getting routine screening mammography may be less than previously reported. As many as one in three women have never had a mammogram or have not had one in more than two years. Furthermore, many women who have had one or two mammograms failed to return for regular screenings.

While screening mammography has been credited with significant improvements in breast cancer outcomes, the success of campaigns to increase screening use have not shown consistent improvements.

In New Hampshire studies assessing use demonstrate that overall use by women 50 years old and older range from 65-82 percent and depend on age. However, these studies rely on self-reporting surveys prone to poor patient recall or single community healthcare facility use.

The researchers found 36 percent of women 40 and over in New Hampshire had either never had a mammogram or had not had one in over 27 months. Older women over 80 years old were more likely than younger women to not receive screening.

Among those women who had received screening in their lifetime, only 65 percent received routine screening within the recommended one to two year interval. The remaining 35 percent had one or two screening mammograms and did not return with 27 months.

The figures only address the need for a critical evaluation regarding the issue as to why women fail to report. An initiative by the breast cancer registry to follow up patients on a long-term basis would be appropriate.


'"/>




Page: 1

Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patient’s perception of health status helps in better recover
7. Patients often assume wrongly that they are allergic to penicillin
8. New FDA Approved Drug NATRECOR For Heart Failure Patients
9. Hemochromatosis Patients Blood is Safe
10. Fifth US Patient Receives Artificial Heart
11. Patients Pressure Would Result In Overprescription
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned ... the David Geffen School of Medicine at UCLA. He trained in Internal Medicine at ... fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: